Anti-herpetic medications

Anti-herpetic medications has been studied in 1 paper since 2025: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Dec 30, 2025: “Anti-herpetic treatment reduces dementia risk: A systematic review and meta-analysis”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on anti-herpetic medications

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country

What is anti-herpetic medications linked with?

1

Studies link anti-herpetic medications with dementia.

Dementia

downin humans1

1 study
  1. Anti-herpetic medications lower the risk of dementia in humans (diagnosed with herpesvirus infection) (aHR=0.77, 95% CI: 0.67-0.89).

    “diagnosed and treated versus diagnosed but untreated (aHR=0.77, 95% CI: 0.67-0.89)”

    Reviewdiagnosed with herpesvirus infection

    Anti-herpetic treatment reduces dementia risk: A systematic review and meta-analysis

    Journal of Alzheimer's disease : JAD

More on Dementia

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months